ADL BioPharma is a Spanish-based Contract Development and Manufacturing Organization (CDMO) with extensive experience in precision fermentation and purification technologies. Leveraging a state-of-the-art facility in León, Spain, ADL BioPharma serves global partners in the pharmaceutical, food ingredients, and cosmetic sectors, offering end-to-end solutions from process development to large-scale commercial manufacturing. The company is committed to innovation, sustainability, and quality, building on decades of expertise in biotechnological production at its historic León site.
The León facility is the core of ADL BioPharma's operations, housing R&D laboratories, pilot plants, extensive industrial-scale fermentation capacity, and downstream purification suites. It supports all stages from process development to commercial manufacturing of APIs and ingredients.
One of Europe's largest fermentation sites with over 2,400 m³ of fermentation capacity. The facility includes advanced downstream processing units, quality control labs, and a dedicated pilot plant for process scale-up and validation. It also has a significant history in the production of antibiotics and other fermented products.
ADL BioPharma cultivates a work environment centered on scientific rigor, teamwork, and continuous improvement. There is a strong focus on innovation, quality assurance (GMP compliance), and operational excellence, empowering employees to contribute to complex biotechnological projects for a global clientele.
The León headquarters is pivotal due to its large-scale, flexible manufacturing capabilities, a highly skilled local workforce specializing in biotechnology, and its historical expertise in fermentation. This allows ADL BioPharma to act as a key European CDMO partner for diverse industries.
While ADL BioPharma's manufacturing and R&D operations are centralized at its León facility in Spain, the company maintains a global commercial presence. It serves clients across Europe, North America, Asia, Latin America, and other international markets through a network of business development professionals and strategic partnerships. ADL BioPharma's services, including process development, scale-up, and GMP manufacturing, are designed to meet global regulatory standards, enabling worldwide product distribution for its partners.
Avenida de Antibióticos, 59-61
León
Castile and León
Spain
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, ADL BioPharma' leadership includes:
ADL BioPharma has been backed by several prominent investors over the years, including:
Based on publicly available information, there have been no major C-level executive hires or exits announced at ADL BioPharma within the last 12 months (approximately mid-2023 to mid-2024). The leadership team, which saw Pilar Enseñat appointed as CEO in January 2023 following the acquisition by WdB, appears to be stable.
Discover the tools ADL BioPharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
ADL BioPharma's specific email format is not publicly disclosed. However, common corporate email patterns include [first_initial][last]@[domain.com] or [first].[last]@[domain.com]. For ADL BioPharma, this would likely be @adlbiopharma.com.
[first_initial][last]@adlbiopharma.com
Format
pensenat@adlbiopharma.com
Example
75%
Success rate
ADL BioPharma Website News • April 24, 2024
ADL BioPharma has been awarded the Silver Medal by EcoVadis, recognizing its strong commitment and performance in sustainability. This places ADL among the top percentile of companies evaluated for their environmental, social, and governance practices, highlighting its dedication to responsible manufacturing....more
ADL BioPharma Website News / Bioriginal • September 12, 2023
ADL BioPharma and Bioriginal Food & Science Corp. have formed a strategic partnership to enhance the production of high-quality Omega-3 ingredients. The collaboration leverages ADL's advanced fermentation expertise and Bioriginal's market leadership in nutritional supplements to meet growing global demand....more
ADL BioPharma Website News • January 17, 2023
ADL BioPharma announced its acquisition by WdB, a financial group specializing in asset management and private equity. This strategic move is set to accelerate ADL's growth, expand its CDMO capabilities in fermentation and purification, and strengthen its position as a leading European biotechnology manufacturer....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including ADL BioPharma, are just a search away.